EFPIA - NEWSLETTER

EFPIA Newsletter 16 July 2026

News

14 July 2026 EFPIA response to UK Switzerland FTA

A blueprint for life sciences trade.

13 July 2026 German Parliament passes Statutory Health Insurance Contribution Stabilization Act: EFPIA response...

The health reforms passed by the German Parliament send a concerning signal about how Germany values its role as a leader...

EFPIA Rentrée 2026

Join us on 7 September for the annual EFPIA Rentrée, marking the start of the new policy season. Bringing together EFPIA members, colleagues and partners, the reception provides an opportunity to reconnect after the summer break, exchange perspectives on the months ahead, and continue the conversations that will shape our work throughout the rest of the year.

Event details:

Monday, 7 September 2026
18:30–20:30 CEST
Residence Palace, Rue de la Loi 155, Brussels

Register here by 21 August.

Europe’s Choice: The value of investing in innovation

If you were unable to join our Conference in person, you can find the recordings here.

Welcome by Stefan Oelrich, EFPIA President and President of Bayer Pharma

Panel 1 - Waking up in a new World Disorder: How to be open to trade, while protecting key industries

Panel 2 - The health dividend: Is investing in medicines a smart choice?

Panel 3 - What would it take for Europe to lead in life sciences?

Events

21 SEP 2026

World Bladder Cancer Patient Forum 2026 Hong Kong and Online

Taking place in Hong Kong this September, the event is also open to remote participants.

Learn more →

29 SEP 2026

EFGCP Better Medicines for Children Conference 2026 Amsterdam, The Netherlands

This year’s Conference offers a wide variety of sessions for attendees, and will feature distinguished speakers from...

Learn more →

What we are reading

Securing Europe’s health sovereignty: From innovation to outcomes 09 July 2026 (European Files)

How the EMA’s Steffen Thirstrup Is ‘Standing Up for Science’ 09 July 2026 (Global Health Now)

UK life sciences attracts £3bn investment, creating jobs and faster patient treatments 09 July 2026 (First Word Pharma)

Clinical Trials at the heart of EU’s competitiveness: Delivering on the promise of the EU Biotech... 07 July 2026 (European Files)

Good practices for delivering high value cancer care in EU countries 24 June 2026 (OECD)

About the EFPIA newsletter

The European Federation of Pharmaceutical Industries and Associations (EFPIA) represents the pharmaceutical industry operating in Europe. Through its direct membership of 37 national associations and 40 leading pharmaceutical companies, EFPIA is the voice on the EU scene of 1,900 companies committed to researching, developing and bringing to patients new medicines that will improve health and the quality of life around the world.

Tel: +32 (0)2 626 25 55
Communications@efpia.eu

▶